Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
CMML: a biologically distinct myeloproliferative disease.
Jorge Cortes
Research output
:
Contribution to journal
›
Review article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CMML: a biologically distinct myeloproliferative disease.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Leukemia, Myelomonocytic, Chronic
100%
Myeloproliferative Disorders
22%
Myelodysplastic Syndromes
19%
Farnesyltranstransferase
13%
Topoisomerase I Inhibitors
12%
Platelet-Derived Growth Factor beta Receptor
11%
Angiogenesis Inhibitors
10%
Imatinib Mesylate
9%
Gene Fusion
9%
Transcriptional Activation
7%
Protein-Tyrosine Kinases
7%
Vascular Endothelial Growth Factor A
7%
Bone Marrow
6%
Therapeutics
2%
Neoplasms
2%